14 November 2021 - A drug to treat a rare stomach and bowel cancer will be subsidised after being listed on the Pharmaceutical Benefits Scheme.
People suffering from advanced gastrointestinal stromal tumour will be able to buy the drug Qinlock for at most $41.30 per script from December, Health Minister Greg Hunt announced on Sunday.